drugset

drugset / Trial / NCT03291041

A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

NCT03291041 ↗

Phase 2 Completed 25 enrolled Vanda Pharmaceuticals

RandomizedParallel-groupDouble-blindTreatment

Summary

A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

Timeline

Start: 2016-07
Primary completion: 2017-11
Completion: 2017-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	tasimelteon	Small molecule	—	Oral

Indications